INFUSION DEVICE - ANVISA Registration 80102512144
Access comprehensive regulatory information for INFUSION DEVICE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102512144 and manufactured by MULTIMEDICAL S.R.L.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SMITHS MEDICAL ASD, INC. (MINNEAPOLIS), UNOMEDICAL A/S, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80102512144
25351425461201870
04718143000194
Company Information
Dates and Status
Nov 12, 2018
VIGENTE
09/18/2025 19:00:01
SMITHS MEDICAL ASD, INC. (MINNEAPOLIS)• United States of America
UNOMEDICAL A/S• Denmark
BARD ACCESS SYSTEMS, INC.• United States of America
ROCHE DIABETES CARE GMBH• Germany
BARD ACCESS SYSTEMS• United States of America
DISPOSITIVO PARA INFUSÃO
Agulha Huber com Dispositivo de Segurança BeCare
ZHEJIANG KINDLY MEDICAL DEVICES CO., LTD.
80808489033
May 05, 2025
DISPOSITIVO PARA INFUSÃO
Dispositivo para infusão intraóssea EZ-IO
TELEFLEX MEDICAL EUROPE LIMITED
80312279031
Jan 13, 2025
DISPOSITIVO PARA INFUSÃO
Sistema de Administração CADD com bolsa ponta spike e extensão Y
SMITHS MEDICAL ASD, INC. (MINNEAPOLIS)
80228999021
Mar 11, 2024
DISPOSITIVO PARA INFUSÃO
Sistema de Administração CADD com bolsa ponta spike, sítio de injeção e filtro
SMITHS MEDICAL ASD, INC. (MINNEAPOLIS)
80228999022
Mar 11, 2024
DISPOSITIVO PARA INFUSÃO
Sistema de Administração CADD com bolsa ponta spike e filtro
SMITHS MEDICAL ASD, INC. (MINNEAPOLIS)
80228999023
Mar 11, 2024

